Edgewise Therapeutics Inc (EWTX)
29.62
-0.36
(-1.20%)
USD |
NASDAQ |
Dec 24, 16:00
Edgewise Therapeutics Free Cash Flow: -110.10M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | -1.352B |
| Catalyst Pharmaceuticals Inc | 221.79M |
| Sarepta Therapeutics Inc | -480.40M |
| Regenxbio Inc | -184.74M |
| Entrada Therapeutics Inc | -17.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.37M |
| Cash from Investing (Quarterly) | 25.36M |
| Cash from Financing (Quarterly) | 3.333M |
| Free Cash Flow Per Share (Quarterly) | -0.2973 |
| Free Cash Flow Yield | -4.38% |